Evaluation of effectiveness of SGLT2 inhibitor on the sleep quality

Evaluation of effectiveness of SGLT2 inhibitor on the sleep quality - Evaluation of effectiveness of SGLT2 inhibitor on the sleep quality

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000054555

Enrollment

Registered

2024-06-03

Start date

2024-06-05

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Type 2 diabetes mellitus

Exclusion criteria

Exclusion criteria: Patients who are taking diuretics Patients with dementia or requiring long-term care, who cannot answer the questionnaire survey by themselves Patients who have added or changed their antidiabetic drugs or insulin injection within the past three months Patients who have had SGLT2 inhibitor within the past six months

Design outcomes

Primary

Measure	Time frame
The difference of change of sleep quality between the patients with type 2 diabetes mellitus with/without SGLT2 inhibitor add-on treatment	—

Secondary

Measure	Time frame
The factors that associate with changes in sleep quality with the use of add-on SGLT2 inhibitors Influence of SGLT2 inhibitor and other antidiabetic drugs on the nocturia	—

Countries

Japan

Contacts

Public ContactYukihiro Inoguchi

Department of Internal Medicine, Kurume University School of Medicine Division of Endocrinology and Metabolism

inoguchi_yukihiro@kurume-u.ac.jp0942-31-7563

Outcome results